Table 1.
Baseline characteristics of all patients (N = 1017).
Patient Characteristics | |
Age (years), mean (range) | 70.0 (60.0–79.0) |
Sex, male, N/% | 601/59.1% |
Weight (kg), mean (range) | 56.0 (48.5–65.4) |
Pre-Existing Comorbidities | |
Liver insufficiency, N/% | 49/4.82% |
Chronic respiratory disorder, N/% | 38/3.74% |
Chronic heart failure, N/% | 66/6.49% |
Chronic kidney disease, N/% | 73/7.18% |
Immunocompromised, N/% | 178/17.5% |
Infection Site | |
Catheter related, N/% | 16/1.57% |
Bone/soft tissue, N/% | 158/15.5% |
Infectious endocarditis, N/% | 25/2.46% |
Central nervous system, N/% | 22/2.16% |
Urinary tract, N/% | 128/12.6% |
Lung, N/% | 230/22.6% |
Abdomen, N/% | 364/35.8% |
Others, N/% | 20/1.97% |
Illness Severity Score on Day 1, Mean (Range) | |
APACHE II score | 23.0 (17.0–29.0) |
SIRS score | 3 (2–4) |
SOFA score, lung | 2 (1–3) |
SOFA score, kidney | 2 (0–3) |
SOFA score, liver | 0 (0–1) |
SOFA score, cardiovascular | 3 (1–4) |
SOFA score, coagulopathy | 1 (0–2) |
SOFA score, central nervous system | 1 (0–2) |
ISTH overt DIC score | 4.0 (3.0–5.0) |
Laboratory Data on Day 1, Mean (Range) | |
White blood cell count (×103/μL) | 11.8 (4.70–19.3) |
Platelet count (×104/μL) | 111 (56.0–180) |
Hemoglobin (g/dL) | 10.5 (8.9–12.2) |
PT ratio | 1.36 (1.20–1.62) |
Fibrinogen (mg/dL) | 386 (263–544) |
FDP (μg/mL) | 20.0 (11.0–40.0) |
D-dimer (μg/mL) | 8.90 (4.30–20.80) |
Lactate (mmol/L) | 2.80 (1.80–5.04) |
Data are presented as the median and interquartile ranges (25th–75th percentile) or as absolute frequencies with percentages. APACHE, Acute Physiology and Chronic Health Evaluation; SIRS score, Systemic Inflammatory Response Syndrome; SOFA, Sequential Organ Failure Assessment; ISTH overt DIC score, International Society on Thrombosis and Haemostasis overt Disseminated Intravascular Coagulation score; PT, prothrombin time; FDP, fibrin/fibrinogen-degradation product.